Mr. President, I ask unanimous consent that the Committee on Armed Services be authorized to meet during the session of the Senate on July 20, 2010, at 9:30 a.m. The PRESIDING OFFICER. Without objection, it is so ordered. Committee on…

Mr. President, I ask unanimous consent that the Committee on Rules and Administration be authorized to meet during the session of the Senate on July 20, 2010, at 2 p.m. The PRESIDING OFFICER. Without objection, it is so ordered. Select…

Mr. President, I ask unanimous consent that the Committee on the Judiciary be authorized to meet during the session of the Senate, on July 20, 2010, at 10 a.m., in SH-216 of the Hart Senate Office Building, to conduct an executive business…

Mr. President, I ask unanimous consent that the Committee on Foreign Relations be authorized to meet during the session of the Senate on July 20, 2010, at 2:30 p.m. The PRESIDING OFFICER. Without objection, it is so ordered. Committee on…

Mr. President, I ask unanimous consent that the Committee on Banking, Housing, and Urban Affairs, be authorized to meet during the session of the Senate on July 20, 2010, at 10 a.m., to conduct a hearing entitled ``Continuing Oversight on…

Mr. President, I rise to talk about an issue we are going to be voting on today, thank goodness. We are going to be voting on an extension of unemployment insurance, which is something many of us in the Senate have tried to pass for many…

Mr. Speaker, as the American people ask where are the jobs, the President's economic advisers reply with weak statistics about the wasteful government stimulus program. All the while, we're losing billions of dollars to tariffs that could…

increasing understanding of the role of genetics in rare diseases will unquestionably have a considerable impact on their diagnosis, prevention, and treatment.

Senator Specter and I introduced Senate bill 406, which would deal with that kind of gap that a lot of families and children have to deal with everyday.

I would like to start off by thanking my colleague and friend Senator Brown for calling this hearing today to draw attention to rare and neglected diseases in children.

For me and for, I think, a lot of Members of Congress, we can't go through a week, or sometimes even a day, without being both informed and inspired by constituents who come to us with a problem, or sometimes more than one problem, and…

But new investments are needed here?

This startling and disturbing fact should evoke not just concern, but action.

the Agency strongly urges Congress to ensure that, if a change is made, the population limit is clearly defined, not variable.

According to recent estimates, international financing for health-related R&D exceeds $160 billion and includes a diversity of sources: 51 percent private for-profit, 41 percent public, and 8 percent private not-for-profit.

the NIH spends a substantial amount on research on various rare diseases, including those affecting children, but with over 6,000 known rare diseases, not every one has been fully addressed.

without a statement of policy on rare diseases and orphan products, it is not possible [for the FDA] to ensure consistency in that process.

Only one colleague is present. He is the congenial junior Senator from Florida. I thank my colleague. I want to make one more point. That is on the issue of the Supreme Court taking more cases. Here again, if there was transparency…